Metraipolis › archive › dc_f64aa791091f

Combined carbon ion radiotherapy and immunotherapy: leveraging the immunological advantages of carbon ion — Europe PMC PMID:41822511

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41822511
DOI
10.3389/fimmu.2026.1747607
License (as archived)
solo-consultazione
Archived
2026-11-05T07:49:10.039Z
SHA-256 of the archived text
470b4cf5a4a75d8653571a6300f315e883f8110453f7db8e3af8536bb811ee71
Stable URL of this page
https://metraipolis.com/documento/dc_f64aa791091f

How to cite

Combined carbon ion radiotherapy and immunotherapy: leveraging the immunological advantages of carbon ion — Europe PMC PMID:41822511 — Europe PMC (en), https://europepmc.org/article/MED/41822511 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f64aa791091f (Metraipolis archive dc_f64aa791091f, sha256 470b4cf5a4a75d8653571a6300f315e883f8110453f7db8e3af8536bb811ee71)
BibTeX
@misc{dcf64aa791091f,
  title = {Combined carbon ion radiotherapy and immunotherapy: leveraging the immunological advantages of carbon ion — Europe PMC PMID:41822511},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41822511},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f64aa791091f; sha256 470b4cf5a4a75d8653571a6300f315e883f8110453f7db8e3af8536bb811ee71},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822511. Agents can read the archived copy with the MCP tool read_document.